Current investments

Receive information about current investment opportunities

Sign in or create an account to receive information about current share issues.

Sign in/Create account

Completed investments

Capitainer

Capitainer supplies intelligent solutions for self-sampling of blood and plasma. The product qDBS is based on DBS (Dried Blood Spot) technology and is designed for easy home sampling of blood with high precision.

Read more
Image showing a nanomolecular structure.

Synartro: 2

Synartro is developing a unique treatment for knee osteoarthritis by combining two proven drugs, which will offer an effective and safe alternative to today’s treatments.

Read more
An enlarged image of nerve cells with nerve fibers, so-called axons.

PharmNovo

PharmNovo develops drugs for chronic pain based on a new type of selective delta opioids. The main candidate PN6047 shows promising results on effective pain relief without negative side effects.

Read more
The Sciety syndicate invests in Synartro Synartro is developing a novel therapy for knee osteoarthritis.

Synartro: 1

Osteoarthritis affects more than 240 million people globally. Synartro is developing a novel therapy for knee osteoarthritis with fewer side effects and improved efficacy to meet the needs of the ageing population.

Read more
Show more

Exits

A waiting room at Medpro Clinic Group.

Medpro

Medpro’s business concept is to acquire and operate healthcare centres and specialist clinics at small locations in Västra Götaland County. They apply a so-called “design-in-healthcare” concept and have a clear client focus.

Read more

Raytelligence

Raytelligence has developed a unique, non-intrusive radar sensor and cloud platform for monitoring vital signs, such as respiration, heartbeat and position and movement. The company is aimed at elderly care in the home.

Read more

Liv Diagnostics

Tumor cell proliferation causes 90% of all cancer deaths. Liv Diagnostics is developing new technology to measure the spreading capacity of tumor cells and provide predictive information on the risk of metastasis.

Read more
Show more